SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-250714
Filing Date
2017-08-08
Accepted
2017-08-08 08:01:55
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d330876d10q.htm 10-Q 564914
2 EX-31.1 d330876dex311.htm EX-31.1 8912
3 EX-31.2 d330876dex312.htm EX-31.2 8892
4 EX-32.1 d330876dex321.htm EX-32.1 5124
  Complete submission text file 0001193125-17-250714.txt   2344577

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aqxp-20170630.xml EX-101.INS 354899
6 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20170630.xsd EX-101.SCH 27254
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20170630_cal.xml EX-101.CAL 39109
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20170630_def.xml EX-101.DEF 71087
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20170630_lab.xml EX-101.LAB 226963
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20170630_pre.xml EX-101.PRE 155149
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 171013280
SIC: 2834 Pharmaceutical Preparations